Actavis: FDA Approves Expanded Label For BOTOX - Quick Facts - Nasdaq

Nasdaq

Actavis: FDA Approves Expanded Label For BOTOX - Quick Facts Nasdaq announced that the U.S. FDA has approved an expansion of the BOTOX (onabotulinumtoxinA) label for the treatment of adults with upper limb spasticity. The company said the expanded label approval for the two thumb flexor muscles is based on two ... and more »